Examining BRAF-Inhibitor Resistance Offers Few Clues in Melanoma Treatment
May 31st 2015Due to the genetic heterogeneity observed in tumors of melanoma patients who developed resistance to BRAF inhibitors, assessing mechanisms of resistance has minimal potential to inform further treatment decisions.